Filana Therapeutics FLNA
NASDAQ FLNA
$0.65 -0.01 (-1.52%)
At close: Oct 22, 2026 · 4:00 PM EDT

Filana Therapeutics (FLNA) Price to Earnings (2013 - 2014)

Updated

Filana Therapeutics' Price to Earnings came in at 54.96 for Q3 2014, down 23.7% from the prior quarter.

Analysis

Filana Therapeutics (FLNA) Price to Earnings (2013 - 2014) Analysis & Trends

For FY2013, Filana Therapeutics' Price to Earnings was 49.08.

  • The five-year range for quarterly Price to Earnings is 49.08 (Q4 2013) to 72.06 (Q2 2014).
  • Business Quant data shows FLNA's Price to Earnings at 72.06 (Q2 2014), 61.60 (Q1 2014) and 49.08 (Q4 2013) in the three quarters before Q3 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Filana Therapeutics 31.40 Mn -339.44 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 54.96
Jun 30, 2014 72.06
Mar 31, 2014 61.60
Dec 31, 2013 49.08
API Access

Filana Therapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=FLNA&period=max&api_key=YOUR_API_KEY